As of March 2026 AgomAb Therapeutics has a market cap of NZ$1.31 Billion. This makes AgomAb Therapeutics the world's 6372th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
On Mar 3rd, 2026 the market cap of AgomAb Therapeutics was reported to be: